High-purity PT-141 (Bremelanotide) is available from PX1 Research for laboratory applications requiring verified chemical structure and reliable lot-to-lot purity. Synthesized in domestic, GMP-compliant facilities, every lot undergoes rigorous third-party testing to guarantee identity, purity, and endotoxin control. Designed exclusively for in vitro and preclinical research into melanocortin receptor signaling, our research compounds ship same-day from California and Arizona.
High-purity PT-141 (Bremelanotide) is available from PX1 Research for laboratory applications requiring verified chemical structure and reliable lot-to-lot purity. Synthesized in domestic, GMP-compliant facilities, every lot undergoes rigorous third-party testing to guarantee identity, purity, and endotoxin control. Designed exclusively for in vitro and preclinical research into melanocortin receptor signaling, our research compounds ship same-day from California and Arizona.
PT-141, chemically designated as Bremelanotide, is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH). Originally derived during the investigation of skin pigmentation pathways associated with melanocortin receptors, researchers observed that specific structural modifications yielded central nervous system activity distinct from cutaneous melanogenesis. Consequently, scientists looking to buy PT-141 do so to investigate central neurochemical signaling pathways rather than peripheral tissue responses.
Structurally, PT-141 possesses the amino acid sequence Cyclo[Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys]-OH, featuring a lactam bridge between the Asp and Lys side chains. This conformational constraint significantly increases chemical stability and receptor selectivity compared to linear α-MSH peptides. Preclinical literature documents PT-141's primary mechanism as a high-affinity agonist at central melanocortin receptors, specifically the MC3R and MC4R subtypes localized in the hypothalamus. Researchers utilize this compound to explore the central coordination of autonomic, neuroendocrine, and behavioral pathways in validated animal models.
When acquiring research-grade reagents, principal investigators must ensure their supply chain provides strict verification of peptide structure, counterion concentration, and freedom from manufacturing contaminants. PX1 Research supplies laboratory-grade research peptides synthesized under stringent quality management protocols to ensure reproducible data in cellular and animal assays.
The primary biochemical utility of PT-141 lies in its selective interaction with the melanocortin receptor family, a group of five distinct G-protein coupled receptors (GPCRs) designated MC1R through MC5R. In vitro binding assays indicate that Bremelanotide acts as a potent agonist primarily at MC3R and MC4R, with intermediate binding affinity at MC1R and minimal activity at MC2R (the adrenal ACTH receptor) or MC5R.
In vitro functional assays demonstrate that binding of PT-141 to central MC4R stimulates heterotrimeric Gs proteins, triggering adenylate cyclase activation and a subsequent intracellular surge of cyclic adenosine monophosphate (cAMP). In rodent brain slices, this intracellular signaling cascade modulates neuronal firing rates within the paraventricular nucleus (PVN) and medial preoptic area (mPOA) of the hypothalamus. Preclinical studies suggest these hypothalamic regions serve as critical central integration nodes for neurovascular and behavioral responses linked to sexual-health pathways.
Unlike peripherally acting vasoactive compounds, PT-141 acts upstream within the central nervous system. Investigation of this central pathway allows researchers to decouple vascular hemodynamics from central neurological initiation. Selecting a thoroughly characterized peptide lot ensures that receptor activation profiles observed during assays reflect the true pharmacology of the molecule rather than artifacts introduced by synthesis side-products.
Investigational models utilizing PT-141 span several areas of neurobiology and neuroendocrinology. Because melanocortin signaling interfaces with multiple homeostatic systems, laboratories employ this cyclic peptide across diverse experimental frameworks:
1. **Central Sexual-Health Pathways:** Preclinical models evaluate how MC4R activation in hypothalamic nuclei coordinates downstream dopamine release in the nucleus accumbens, modulating reward pathways and behavioral motivation.
2. **Neuroendocrine and Metabolic Crosstalk:** In vitro data indicate that central MC3R and MC4R signaling pathways cross-regulate energy homeostasis, satiety pathways, and systemic inflammation, providing a broader context for neuroendocrine studies.
3. **Comparative Receptor Kinetics:** Researchers utilize PT-141 alongside full-spectrum melanocortin agonists to map ligand-binding dynamics, GPCR internalization rates, and downstream beta-arrestin recruitment profiles.
4. **Microvascular Modulation:** Animal studies investigate the secondary neurovascular effects triggered by central autonomic activation following intracerebroventricular or systemic administration.
The integrity of experimental outcomes depends directly on reagent quality. Institutional procurement teams often evaluate whether to acquire compounds from low-cost overseas distributors or dedicated domestic suppliers. Research compounds imported from unverified international manufacturers frequently carry hidden technical risks that compromise assay validity.
Overseas suppliers frequently ship crude or semi-purified peptides that rely on uncalibrated, in-house testing methods. Common issues encountered in unverified lots include trityl adducts, incomplete deprotection sequences, residual trifluoroacetic acid (TFA) salts, and high levels of bacterial endotoxins. Furthermore, overseas shipping introduces exposure to unmonitored ambient temperatures, causing peptide degradation and aggregation during long transit periods.
PX1 Research eliminates these vulnerabilities by conducting all synthesis and analytical validation within domestic USA facilities operating under GMP guidelines. Every lot of PT-141 is purified using preparative reverse-phase high-performance liquid chromatography (RP-HPLC) and lyophylized under cleanroom conditions. Orders ship directly from our climate-controlled facilities in California and Arizona via same-day fulfillment (Monday through Friday), preserving peptide integrity from synthesis to laboratory bench.
To guarantee quantitative reproducibility, PX1 Research subjects every production lot to a rigorous battery of analytical testing performed by independent, ISO 17025-accredited laboratories. Research institutions are provided with a complete Lot-Specific Certificate of Analysis (COA) detailing the exact chemical parameters of their shipment.
Purity is measured using analytical RP-HPLC with ultraviolet detection at 214 nm and 280 nm. PX1 requires a baseline purity threshold of ≥98.0%, ensuring that micro-heterogeneities and deletion sequences are minimized. Sequence identity is verified via Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF), confirming the theoretical monoisotopic mass of 1024.18 Da without unexpected adduct ions.
Equally critical for cell culture and in vivo animal models is the monitoring of bacterial endotoxins. Gram-negative lipopolysaccharides (LPS) can induce severe inflammatory responses, invalidating neuroendocrine and vascular research data. PX1 subjects every lot to a kinetic chromogenic Limulus Amebocyte Lysate (LAL) assay, guaranteeing endotoxin levels strictly below <0.01 EU/mg. Review our complete protocol on peptide purity testing to understand our verification framework.
When designing protocols within the melanocortin pathway, researchers must select the analog that best isolates their target mechanism. The table and detailed analysis below illustrate structural and functional distinctions among prominent melanocortin research compounds:
While Melanotan II acts as a non-selective agonist across MC1R, MC3R, MC4R, and MC5R—frequently triggering potent peripheral melanogenesis alongside central effects—PT-141 was specifically developed by removing the lipophilic aromatic modifications that drive non-selective receptor engagement. Consequently, PT-141 demonstrates enhanced selectivity for central MC3R/MC4R pathways over peripheral MC1R responses.
Similarly, Melanotan I (Afamelanotide) is a linear peptide engineered primarily for selective MC1R interaction in cutaneous biology. For researchers studying central neuroendocrine and reward circuitry without melanogenic confounding variables, PT-141 represents the more isolated pharmacological probe. In complex neurochemical assays, researchers may also evaluate upstream peptidergic controllers such as Kisspeptin-10 when studying gonadotropin-releasing hormone (GnRH) axis interactions.
Maintaining structural stability during handling is essential for preserving ligand-binding affinity. PT-141 is delivered as a sterile, lyophilized cake packaged in sealed USP Type I glass vials under inert argon gas.
1. **Lyophilized Storage:** Upon receipt, store intact vials in a dark freezer at -20°C for short-term preservation or -80°C for long-term storage. Avoid exposure to light and ambient humidity.
2. **Reconstitution Procedure:** Allow the vial to equilibrate to room temperature prior to reconstitution to prevent moisture condensation. Reconstitute using sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4), depending on assay requirements.
3. **Dissolution Technique:** Direct the solvent stream down the inner glass wall rather than directly onto the lyophilized powder. Gently swirl the vial until fully dissolved; never vortex or vigorously agitate the solution, as shear stress can cause peptide aggregation.
4. **Reconstituted Stability:** Store reconstituted liquid aliquots at 2°C to 8°C and use within 30 days. For long-term usage, prepare single-use aliquots and freeze at -20°C to avoid repeated freeze-thaw cycles.
In the competitive landscape of scientific research, experimental repeatability is non-negotiable. PX1 Research operates as a dedicated partner for academic institutions, biotechnology firms, and contract research organizations (CROs). We eliminate common sourcing risks through an uncompromising, transparent quality control architecture.
Every batch of PT-141 offered in our catalog undergoes rigorous quality control from raw amino acid sourcing through final packaging. By maintaining full traceability and providing transparent analytical data for every lot, PX1 protects your lab from compromised reagents, lost grant funding, and unrepeatable assay results. Explore our comprehensive research library for technical whitepapers and mechanistic guides detailing our analytical methodology.
For high-throughput screening facilities, long-term animal studies, or institutional research programs requiring multi-gram quantities, PX1 Research offers tailored supply solutions. Our domestic synthesis capacity allows us to deliver custom batch sizes with custom TFA-to-acetate counterion conversions, specialized aliquot volumes, and dedicated batch reservation.
Principal investigators and procurement managers can establish institutional accounts through our wholesale portal to access specialized pricing tiers, dedicated technical support, and batch-reserved inventory guarantees. Every wholesale batch maintains the identical ISO 17025 COA, endotoxin testing, and USA synthesis standards applied to our standard catalog items.
What is the certified purity level of PX1 Research PT-141?
Every lot of PT-141 supplied by PX1 Research is verified at ≥98.0% chemical purity using analytical RP-HPLC. Detailed chromatography profiles are included in the downloadable Certificate of Analysis provided with each purchase.
How is lot-specific quality verified?
Testing is conducted by independent, ISO 17025-accredited analytical laboratories using High-Performance Liquid Chromatography (RP-HPLC) for purity and Mass Spectrometry (ESI-MS/MALDI-TOF) for exact molecular weight verification.
What endotoxin standards does PX1 enforce for PT-141?
All PT-141 lots undergo kinetic chromogenic Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels remain below <0.01 EU/mg, making them suitable for sensitive cell culture and in vivo preclinical assays.
Where does PX1 Research ship PT-141 from?
All orders are fulfilled directly from our domestic climate-controlled distribution facilities in California and Arizona. Orders placed Monday through Friday before our daily cutoff ship the same day.
What molecular targets are primary for PT-141 in laboratory models?
PT-141 is a synthetic peptide agonist primarily targeting the central melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors in the central nervous system.
How should lyophilized PT-141 be stored upon arrival?
Unopened, lyophilized vials should be stored at -20°C for standard storage or -80°C for extended archival storage, protected from light and moisture exposure.
Which solvents are recommended for reconstituting PT-141 in a lab setting?
PT-141 readily dissolves in sterile Bacteriostatic Water or sterile Phosphate-Buffered Saline (PBS, pH 7.4). Solvents should be selected based on specific in vitro or in vivo assay protocols.
Can institutions purchase PT-141 in bulk or custom batch sizes?
Yes, PX1 Research provides institutional accounts, custom synthesis, and bulk batch allocations for qualifying academic, CRO, and corporate research laboratories through our wholesale division.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.